Dr. Jonathan Rosenberg, MD
Claim this profileMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Studies Bladder Cancer
Studies Transitional Cell Carcinoma
5 reported clinical trials
10 drugs studied
Area of expertise
1Bladder Cancer
Stage IV
Stage III
2Transitional Cell Carcinoma
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Jonathan Rosenberg, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 210 criteria
Nivolumab +/− Ipilimumab Before Surgery
for Bladder Cancer
The purpose of this study is to test if immunotherapy with nivolumab alone or in combination with ipilimumab is safe and does not delay the planned bladder cancer surgery. The investigators want to see if treatment with these drugs prior to surgery may decrease the size of the bladder cancer and thus could help make the surgery more successful.
Recruiting1 award Phase 25 criteria
More about Jonathan Rosenberg, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jonathan Rosenberg, MD has experience with
- Enfortumab Vedotin
- Gemcitabine
- Ipilimumab
- Nivolumab
- Radical Cystectomy
- Radical Surgery
Breakdown of trials Jonathan Rosenberg, MD has run
Bladder Cancer
Transitional Cell Carcinoma
Locally Advanced
Unresectable
Endometrial Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Rosenberg, MD specialize in?
Jonathan Rosenberg, MD focuses on Bladder Cancer and Transitional Cell Carcinoma. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jonathan Rosenberg, MD currently recruiting for clinical trials?
Yes, Jonathan Rosenberg, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Rosenberg, MD has studied deeply?
Yes, Jonathan Rosenberg, MD has studied treatments such as Enfortumab Vedotin, Gemcitabine, Ipilimumab.
What is the best way to schedule an appointment with Jonathan Rosenberg, MD?
Apply for one of the trials that Jonathan Rosenberg, MD is conducting.
What is the office address of Jonathan Rosenberg, MD?
The office of Jonathan Rosenberg, MD is located at: Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center (All Protocol Activities).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.